Dr. Christoph Rösli

Dr. Christoph Rösli is Head of Platforms at Swiss TPH and a member of the Executive Team. In this role, he leads the institute’s scientific platforms and core facilities, including Biostatistics and Data Management, the Central Laboratory, the BSL-3 Laboratory, Cohorts and Biobanks, Projects and Grants, and Research Informatics.

Christoph holds a PhD in Pharmaceutical Sciences from ETH Zürich and completed a postdoctoral fellowship at the Institute of Pharmaceutical Sciences at ETH Zürich. He has contributed to numerous scientific publications and two patents.

He has more than 15 years of experience in academic institutions and the pharmaceutical industry, with a focus on research and development, scientific platforms and organisational change. Before joining Swiss TPH, he was Director of Research Platforms at CSL Behring in Bern, where he led platforms in gene therapy and analytical biochemistry. Previously, he held leadership roles at Novartis Pharma AG in Basel and Sandoz Biopharmaceuticals in Germany.